Dr. Hammers on Challenges With CAR T-Cell Therapy in RCCByHans Hammers, MD, PhDSeptember 16th 2019Hans Hammers, MD, PhD, associate professor of internal medicine, Division of Hematology-Oncology, UT Southwestern Medical Center, discusses the challenges with using CAR T-cell therapy in renal cell carcinoma.